A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study are to determine whether a test dose program for taxanes will
reduce the rate and/or severity of hypersensitivity reactions (HSR); and to determine whether
a test dose program for taxanes will result in cost reduction due to decreased drug wastage.